Magdalena K.
- Country
- Poland
- Department
- NA
Research Overview
- A Phase 2b Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Ritlecitinib in Adult Participants with Chronic Spontaneous Urticaria
- Phase 1 Single-Ascending Dose Study Assessing Safety, Tolerability, and Pharmacokinetics of PF-07832837 in Healthy Adults and Adults with Atopic Dermatitis
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating Izokibep Efficacy and Safety in Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 129 of 318 partner sites.
Specializations
Inflammatory Skin Conditions
The investigator specializes in treating chronic inflammatory skin disorders, with particular focus on atopic dermatitis and plaque psoriasis. Their research encompasses innovative therapeutic approaches for managing moderate to severe manifestations of these conditions.
- Atopic Dermatitis Management
- Plaque Psoriasis Treatment
- Novel Biologic Therapies
Dermatological Disorders
Expertise extends to various dermatological conditions including hidradenitis suppurativa, acne vulgaris, and chronic urticaria. The investigator evaluates advanced therapeutic options for these challenging skin conditions.
- Hidradenitis Suppurativa Care
- Acne Treatment Protocols
- Urticaria Management
Autoimmune Skin Disorders
The investigator focuses on autoimmune-related skin conditions, particularly alopecia areata and vitiligo. Their work involves evaluating innovative treatments for these challenging autoimmune manifestations.
- Alopecia Areata Interventions
- Vitiligo Treatment Approaches
- Long-term Disease Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.